Telehealth came to the fore in in 2020 and 2021 as healthcare systems struggled to deal with the consequences of the pandemic, but the coming year could see big changes to the sector after
Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients, and has now added artificial intelligence capabilities with an agreement to
The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet's Verily Life Sciences in 2016.
Akili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I in a deal that will take it into public hands with a valuation